eCite Digital Repository
TGR5 contributes to ursodeoxycholic acid (UDCA)-mediated improvements in glucose regulation in mice
Citation
Jayasinghe, S and Garibay, D and Chouinard, T and Cummings, B, TGR5 contributes to ursodeoxycholic acid (UDCA)-mediated improvements in glucose regulation in mice, 2017 Keystone Symposia Conference, 3 - 7 March 2017, Monterey, California (2017) [Conference Extract]
![]() | PDF Pending copyright assessment - Request a copy 89Kb |
Abstract
Bile acids (BAs) are amphipathic steroid derivatives, whose primary action is the solubilization
of dietary lipids. However, BAs also play a critical role in glucose regulation. Numerous
subtypes of BAs exist and they exhibit wide variation in their impact on glucose regulation. In
particular, the BA subtype UDCA improves insulin sensitivity by decreasing endoplasmic
reticulum (ER) stress and thus has been described as a "chemical chaperone." The mechanism by
which UDCA decreases ER stress and improves insulin sensitivity remains undefined. BAs
signaling through Farnesoid X receptor (FXR) and TGR5 has been shown to improve glucose
homeostasis. However, UDCA is an agonist for TGR5, but not FXR. TGR5 is a transmembrane
G-protein coupled receptor with potent glucoregulatory benefits. Furthermore, as a hydrophilic
BA subtype, UDCA is more likely to signal through a membrane-bound receptor than a nuclear
receptor. Therefore, we tested the hypothesis that TGR5 contributes to the glucoregulatory
benefits of UDCA supplementation. Tgr5+/+ (WT) and Tgr5-/-
(KO) mice received high fat diet
(HFD) with (WT UDCA, KO UDCA) and without (WT CON, KO CON) UDCA
supplementation (n=8-10 per group). UDCA-treated mice received UDCA mixed in the diet such
that animals consumed 150 mg/kg/d UDCA. Body weight, food intake and adiposity did not
differ between groups. During and oral glucose tolerance test (OGTT), UDCA improved glucose
tolerance in Tgr5+/+ but not in Tgr5-/- mice (Glucose AUC (mg/dl x 120 min): WT CON =
38991±2080, WT UDCA = 33961±917, KO CON = 34394±954, KO UDCA = 36759±2800;
P<0.05 WT CON vs WT UDCA). Insulin and glucagon-like peptide-1 (GLP-1) secretion did not
differ between groups. Together, our data show that TGR5 contributes to the glucoregulatory
benefits of UDCA treatment, independently of GLP-1.
Item Details
Item Type: | Conference Extract |
---|---|
Keywords: | glucose regulation, bile acid |
Research Division: | Biological Sciences |
Research Group: | Biochemistry and cell biology |
Research Field: | Systems biology |
Objective Division: | Health |
Objective Group: | Specific population health (excl. Indigenous health) |
Objective Field: | Neonatal and child health |
UTAS Author: | Jayasinghe, S (Dr Sisitha Jayasinghe) |
ID Code: | 146887 |
Year Published: | 2017 |
Deposited By: | Health Sciences |
Deposited On: | 2021-10-01 |
Last Modified: | 2021-11-24 |
Downloads: | 0 |
Repository Staff Only: item control page